@drtimos.bsky.socialHow to win in #Oncology and #Hematology in 2025
📥 Get a FREE #LucidQuest Report http://dlvr.it/TVhmxL
🚀 Oncp/hema drug development is evolving fast. AI-driven Dx, novel MoAs & outcomes-based pricing are reshaping the landscape.
🏆 Who’s leading? AbbVie, Amgen, AZ, BMS, J&J & Novartis.
@drtimos.bsky.socialLucidQuest YouTube > Endocrinology Strategic Roundup | Aug 25- Sep 28, 2026: From August 25 to September 28, 2026, endocrinology competition expanded beyond biochemical control into outcomes, treatment convenience, earlier detection and disease biology.… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.social💉 Vaccines & Infectious Diseases 🦠
#LucidQuest equips BioPharma & investors with real-time insights to outpace the curve.
📩 [email protected] or http://dlvr.it/TVhW6F
#Vaccines #InfectiousDiseases #BioPharma #DueDiligence #LifeScienceStrategy
@drtimos.bsky.social🧬 Gene & Cell Therapy | #RareDiseases 🚀
#LucidQuest delivers sharp insights to help biotechs, investors & BD teams stay ahead in fast-moving markets.
📩 [email protected] or http://dlvr.it/TVhS2K
#GeneTherapy #CellTherapy #Biotech #DueDiligence #InvestmentInsights
@drtimos.bsky.socialMost biopharma launch plans fail not on intent, but on untested response. Competitors counter. Payers retaliate. Regulators reshape rules.
#LucidWargames stress-tests commercial decisions against adversarial behavior, before they’re irreversible.
@drtimos.bsky.socialWin AI search for your brand: structure trials (PMC), align patient portals, publish side-by-sides, frame safety, and own your canonicals.
More: http://dlvr.it/TVgxZz #AIsearch #HealthcareAI #LucidQuest
@drtimos.bsky.socialAI shapes how patients & clinicians find you. Be consistent across sources, make trials citable, answer comparative queries, and audit AI outputs.
Learn how: http://dlvr.it/TVgh7H #AIsearch #HealthTech #LucidQuest
@drtimos.bsky.social🧠 Competitive Insights for #BioPharma and #HealthTech 🚀
#LucidQuest arms #pharma & #biotech with real-time intel to outpace rivals from R&D to market.
📩 [email protected] or http://dlvr.it/TVgdHV
#CompetitiveIntelligence #Strategy #MarketAccess
@drtimos.bsky.social📊 Investment Insights | Advisory | #Fundraising 🚀
At #LucidQuest we help funds & founders turn intelligence into alpha—fast, evidence-based answers before capital moves.
📩 [email protected] or http://dlvr.it/TVgLDk
#VentureCapital #PrivateEquity #HedgeFunds #DealFlow
@drtimos.bsky.social🚀 #DigitalHealth | #AI | #IoE 🌐
At #LucidQuest, we turn bold ideas into patient-centric, AI-powered solutions for #Pharma, #Biotech & #HealthTech.
Let’s shape the future of care together.
📩 [email protected] or
@drtimos.bsky.social👋 CGT and RNA peers, what is the single 90 day challenge blocking you? Share in 60 seconds: http://dlvr.it/TVg630
Then join the Gene, Cell and RNA Therapy Strategy Network: http://dlvr.it/TVg634
@drtimos.bsky.social🚀 Contributed to FirstWord report on AI in personalized medicine: smarter trials, faster discovery 🧬💊. Early AI drugs show 80–90% Ph 1 success! 🌍 Challenges remain, but partnerships & continuous learning will drive the future. #LucidQuest
Read more 👉 http://dlvr.it/TVg4Dn
@drtimos.bsky.socialLucidQuest YouTube > Public Health Strategic Roundup | Aug 21 - Sep 24, 2026: From August 21 to September 24, 2026, public-health research pointed toward a more contextual view of prevention in which dose, intensity, timing, exposure pattern, and evidence… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.socialLucidQuest YouTube > Public Health Strategic Roundup: Lifestyle, Risk and Population Health | Aug 21 - Sep 24, 2026: The latest edition of the Public Health Strategic Roundup, covering developments from August 21 to September 24, 2026, highlights a broader… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.social🚨 Who’s leading BioPharma (+ Google) CVC in 2025?
🔎 #LucidQuest analyzed 22 CVCs—focus by Tech & Therapy Areas + shifts vs. 2023.
Grab the FREE snapshot ⚡
@drtimos.bsky.socialYour launch may look great on Google, but AI answers can cite others. #LucidScope tracks perception + answer differences across models and personas, with source tracing and risk flags. Start with an AI Answer Audit: http://dlvr.it/TVdPC1 #LucidQuest
@drtimos.bsky.socialZero-click is here: AI summaries decide what gets seen. #LucidScope benchmarks how major models describe you vs competitors, spots outdated or hallucinated claims, and recommends content + schema actions. Request an audit: http://dlvr.it/TVdFl0 #LucidQuest
@drtimos.bsky.social🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TVcYX2 #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII
@drtimos.bsky.social🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVcPqP #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@drtimos.bsky.socialLucidQuest YouTube > Immunology Strategic Roundup | Aug 18 - Sep 22, 2026: From 18 August to 22 September 2026, immunology showed a sharper contrast between expansion and constraint, as validated mechanisms moved into new diseases while autoimmune CAR-T… Subscribe for more! #LucidQuest #PharmaCI